🔎 Trials Near Me

Pradžia › Migrena › Tennessee

Migrena klinikiniai tyrimai Tennessee

8 tyrimai dėl Migrena ieško dalyvių vietose Tennessee.

Miestai Tennessee

Oficialus tyrimo tekstas (anglų kalba)

Study of EVO756 in Adults With Migraine

  • Campbell Clinical Research, Franklin
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07616128

MMA Embolization for Refractory Chronic Migraine

  • Semmes Murphey Foundation, Memphis
Renkami dalyviai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06735833

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • Access Clinical Trials Inc /ID# 270280, Nashville
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

  • University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Renkami dalyviai
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-09-21 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Vanderbilt Medical Center, Nashville
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Access Clinical Trials, Inc. /ID# 228002, Nashville
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-14 · NCT05125302

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

  • Clinical Research Associates, Inc., Nashville
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07646613

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • WR-ClinSearch, LLC, Chattanooga
  • Access Clinical Trials, Inc, Nashville
  • Clinical Research Associates, Inc., Nashville
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07645924

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.